A company in Israel called CannaMore Biotechs tested a new medicine made from a substance called CBD, which comes from cannabis plants. They wanted to see if it could help people with a disease called ulcerative colitis, which affects the large intestine and causes pain, diarrhea, and other problems. The trial, or test, was successful, meaning that the medicine seemed to work well and safely for most patients. This is good news for people with ulcerative colitis and for the cannabis industry, as it shows that CBD might be a useful treatment for this condition. Read from source...

"Promising Results In Medical Cannabis: CannaMore's Successful Phase 2a Trial For Colitis Treatment"

Neutral
Article's Key Points:
- CannaMore Biotechs, an Israel-based clinical-stage company, announced the successful completion of its Phase 2a clinical trial for a CBD-based ulcerative colitis treatment.
- The study achieved its primary endpoint, showing a reduction in Mayo scores, indicating a decrease in disease severity.
- Most participants reported substantial improvements in symptoms like reduced abdominal pain and better overall well-being.
- The formulation was well-tolerated, with no significant side effects, confirming its safety profile.
- The company plans to advance to the next stage of clinical trials to further evaluate the long-term efficacy and safety of the treatment.